IN THE CONGRESS OF THE UNITED STATES
APRIL12,2020
Mr.EMPERIO(forhimself,Mr.BEAN,Ms.BERRY,Mr.BO,Mr.CAMPBELL,Mr.
CROSS,Mr.CUBE,Mr.HAINES,Mr.HERSEY,Mr.HILL,Mr.LaMONTAGNE,Mr.
MCKENNA,Mr.PETE,Mr.RICCA,Mr.ROCKEFELLER,Ms.SERYNE,Mr.SONNMr.
VITA)introducedthefollowingbill;
A BILL
A
Toallowgreateraccesstosafeandeffectivecontraception.
BeitenactedbytheHouseofRepresentativesoftheUnitedStatesofAmericainCongress
Assembled,
SECTION1.SHORTTITLE;ETC.
(a) SHORTTITLE.—ThisActmaybecitedasthe“ContraceptionAccessibilityAct”,or
acronymicallyasthe‘CAA’
(b) REFERENCETOTHESECRETARY.—Exceptasotherwiseexpresslyprovided,inthis
Act,the“Secretary”referstotheSecretaryofHealthandHumanServices.
SECTION2.FINDINGS.
(a) Whereascertaincontraceptivessuchas‘PlanB’,containingdosagesuptothree
timeslargerthanthesameformulaofthedailyoralcontraceptive,aredesignatedas
“over-the-counter”drugs,whileothersmallerdosagecontraceptivedrugsstill
requireprescription.
(b) Over43millionwomenareatriskofunintendedpregnancy.In2011,45percentof
allpregnanciesintheUnitedStateswereunintended.
(c) Unintendedpregnanciescostbillionsofdollarseachyear.
(d) Expandingaccesstobirthcontrolcanmitigatefinancialburdensaswellasthe
emotionalandphysiologicalconsequencesofanunintendedpregnancy.

SECTION3.FAST-TRACKINGTHEAPPLICATIONPROCESSFORNON-PRESCRIPTION
CONTRACEPTIVEDRUGS.
(a) PRIORITYREVIEW.—TheSecretaryshallgivepriorityreview(asdefinedin21U.S.C.
360ff(a)(1))toanysupplementalapplicationsubmittedundersection505(b)ofthe
FederalFood,Drug,andCosmeticAct(21U.S.C.355(b))foranycontraceptivedrug
grantedthat—
(1) theapplicationiswithregardtoadrugintendedforregularuse;and
(2) theapprovalofsuchanapplication,withrespecttoindividualsoftheage18
orolder,wouldexemptsuchadrugfromsection503(b)(1)oftheFederal
Food,Drug,andCosmeticAct(21U.S.C.353(b)(1))
(b) WAIVINGOFFEES.—TheSecretaryshallwaivethefeesundersection736(a)(1)of
theFederalFood,DrugandCosmeticAct(21U.S.C.379h(a)(1))withregardtoa
supplementalapplicationreceivingpriorityreviewundersubsection(a).
(c) OVER-THE-COUNTERAVAILABILITY.—Regardlessofanyotherprovisionoflaw,with
respecttoindividualsoftheage18orolder,acontraceptivedrugeligibleforpriority
review(undersubsection(a))shallbesubjecttosection503(b)(1)oftheFederal
Food,Drug,andCosmeticAct(21U.S.C.353(b)(1)),includingaftersucha
supplementalapplication’sapprovalundersubsection(a)(2).
SECTION4.INCREASINGFREEDOMFORWOMENTOMAKETHEIROWNDECISIONS.
(a) REPEALONTAXFOROVER-THE-COUNTERDRUGSMEDICATION.—
(1) HEALTHSAVINGSACCOUNTS.—Subparagraph(A)ofsection223(d)(2)of
theInternalRevenueCodeof1986isamendedbystriking“Suchterm”and
allthatfollowsthroughtheperiod.
(2) ARCHERHEALTHSAVINGSACCOUNTS.—Subparagraph(A)ofsection
220(d)(2)oftheInternalRevenueCodeof1986isamendedbystriking“Such
term”andallthatfollowsthroughtheperiod.
(3) ARRANGEMENTSANDHEALTHREIMBURSEMENTARRANGEMENTSFOR
HEALTHFLEXIBLESPENDING.—Section106oftheInternalRevenueCodeof
1986isamendedbystrikingsubsection(f)andbyredesignatingsubsection
(g)assubsection(f).

(4)EFFECTIVEDATES.—
(A)SAVINGSACCOUNTS.—Theamendmentsmadeinparagraph(1)and(2)
shallbewithrespecttoamountspaidwithrespecttothetaxableyears
beginningDecember31st,2020.
(B)REIMBURSEMENTS.—Theamendmentmadebyparagraph(3)shall
applytoexpensesincurredwithrespecttotaxableyearsbeginningafter
December31,2019.
(b) REPEALOFLIMITATIONSONCONTRIBUTIONSTOFLEXIBLESPENDING
ACCOUNTS.—
(1) INGENERAL.—Section125oftheInternalRevenueCodeof1986isamended
bystrikingsubsection(i)
(c) EFFECTIVEDATE.—Theamendmentmadebythissectionshallapplytotaxable
yearsbeginningDecember31st,2020.